News Image

These stocks are moving in today's after hours session

By Mill Chart

Last update: Mar 15, 2024

Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.

Gainers

TickerChangeComment
TPHS35.56%In the after-hours session on Friday, TRINITY PLACE HOLDINGS INC (NYSEARCA:TPHS) experienced a notable 35.56% increase, driving its shares to $0.11. Only today these shares were declining by -36.22%, so we see a bit of recovery during the after hours session.
HLTH12.44%Promising after-hours performance observed for CUE HEALTH INC (NASDAQ:HLTH) as its shares surged 12.44% to $0.22 during Friday's after-hours trading. Following a -10.82% loss in the regular session, NASDAQ:HLTH is displaying signs of recovery during the after-hours session.
HCP11.47%Impressive after-hours gains for HASHICORP INC-CL A (NASDAQ:HCP) as its stock price advanced 11.47% to $29.54 during Friday's after-hours session.
USAS10.73%AMERICAS GOLD AND SILVER COR (NYSEARCA:USAS) exhibits strong performance after hours, with shares rising 10.73% to $0.23 during Friday's after-hours session. The stock is trading 46.54% lower than 6 months ago.
TANH10.61%TANTECH HOLDINGS LTD's (NASDAQ:TANH) shares rose 10.61% to $0.73. Shareholders saw the stock price going 23.75% lower in the past month.
COOK10.4%TRAEGER INC (NYSE:COOK) rose 10.4% to $2.44 during Friday's after hours session. In the last 6 months the stock lost 44.75%.
BSGM9.39%BIOSIG TECHNOLOGIES INC (NASDAQ:BSGM) showcases remarkable after-hours performance, with a 9.39% rise to $0.58 during Friday's after-hours trading. The stock is trading 31.94% lower than a month ago.
HNRA8.97%HNR ACQUISITION CORP (NYSEARCA:HNRA) showcases remarkable after-hours performance, with a 8.97% rise to $3.4 during Friday's after-hours trading. Yesterday the company had a press release: HNR Acquisition Corp. (NYSE: HNRA) Surges on Untapped Oil Discovery in Permian Basin; Houston Natural Resources Corp. (OTC: HNRC) Stocks Rally.
OPTN7.98%OPTINOSE INC (NASDAQ:OPTN) exhibits strong performance after hours, with shares rising 7.98% to $2.03 during Friday's after-hours session. In the last month the share price increased with 39.26%.
EVA7.94%ENVIVA INC's (NYSE:EVA) shares rose 7.94% to $0.45 during Friday's after hours session. Today's after-hours session indicates a recovery for NYSE:EVA after suffering a -16.17% loss in the regular trading day. A press release (Enviva Announces Court Approval of DIP and the Commencement of the DIP Syndication Process) was released earlier today.

To see the full list of after hours gainers you can use our after hours gainers page.

After hours losers

TickerChangeComment
ADD-13.54%COLOR STAR TECHNOLOGY CO-A's (NASDAQ:ADD) shares fell 13.54% to $0.23. In the last 3 months the share price dropped with 31.77%.
LPTV-10.96%LOOP MEDIA INC's (NYSEARCA:LPTV) stock price decreased by 10.96% to $0.44. Following a 33.3% increase in the regular trading session, NYSEARCA:LPTV is showing signs of weakness with a 10.96% decline in after-hours trading.
BETR-10.14%BETTER HOME & FINANCE HOLDIN's (NASDAQ:BETR) shares declined by 10.14% to $0.48 during Friday's after-hours session. After registering a 18.96% gain earlier today, NASDAQ:BETR is experiencing a 10.14% decline in today's after-hours session.
ALCE-8.73%ALTERNUS CLEAN ENERGY INC's (NASDAQ:ALCE) shares fell 8.73% to $0.53 during Friday's after hours session. Prices are quite volatile now: this is a reversal from 25.05% gain.
MTC-8.64%MMTEC INC's (NASDAQ:MTC) stock price is declining with 8.64% to a price of $2.01. The positive momentum earlier in the day is waning as NASDAQ:MTC retraces 38.36% during the after-hours session.
MTNB-8.2%Following a 26.0% loss in the regular session, NYSEARCA:MTNB exhibits further decline during today's after-hours session. The positive momentum earlier in the day is waning as NYSEARCA:MTNB retraces 26.0% during the after-hours session.
VERB-7.53%The after-hours session reflects NASDAQ:VERB's ongoing correction after experiencing a 211.0% loss in the regular trading hours. Prices are quite volatile now: this is a reversal from 211.0% gain.
LIAN-7.33%LIANBIO-ADR's (NASDAQ:LIAN) shares fell 7.33% to $0.32. NASDAQ:LIAN already had a hard day: closing -93.03% lower during the regular session.
SMX-7.19%SMX SECURITY MATTERS PLC's (NASDAQ:SMX) shares declined by 7.19% to $0.15 during Friday's after-hours session. Price volatility intensifies as NASDAQ:SMX retraces its 24.42% gain during the after-hours session. A press release (Security Matters (SMX) Technology Is A Game Changer To Enhancing Homeland Security And Supply Chain Integrity ($SMX)) was released two days ago.
SEMR-6.98%SEMRUSH HOLDINGS INC-A's (NYSE:SEMR) stock price saw a decrease of 6.98% to $10.4 during Friday's after-hours session. Shareholders saw the stock price going 28.8% higher is the past 6 months.

Our after hours losers page will show you the full list.

Back

MATINAS BIOPHARMA HOLDINGS I

NYSEARCA:MTNB (4/26/2024, 7:05:21 PM)

After market: 0.1793 +0 (+0.22%)

0.1789

0 (-1.43%)

MTNB News

News Image25 days ago - Matinas BioPharma Holdings, Inc.Matinas BioPharma Prices $10 Million Registered Direct Offering

BEDMINSTER, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) (“Matinas BioPharma” or the “Company”), a...

News Imagea month ago - InvestorPlaceMTNB Stock Earnings: Matinas BioPharma Hldgs Reported Results for Q4 2023

Matinas BioPharma Hldgs just reported results for the fourth quarter of 2023.

News Imagea month ago - Matinas BioPharma Holdings, Inc.Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update

Clear registration pathway and FDA agreement on the ORALTO Phase 3 trial for MAT2203 represent critical steps forward and supports partnership discussions

News Imagea month ago - Matinas BioPharma Holdings, Inc.Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation

Daily oral LNC-docetaxel, at a total administered dose of more than 8x greater than IV-docetaxel, showed no evidence of weight loss, compared to an average...

News Imagea month ago - Matinas BioPharma Holdings, Inc.Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response

BEDMINSTER, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company...

News Imagea month ago - Matinas BioPharma Holdings, Inc.Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards

BEDMINSTER, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company...

News Image2 months ago - Matinas BioPharma Holdings, Inc.Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis

ORALTO Phase 3 trial focused on desired initial target indication of early oral step-down treatment of invasive aspergillosis infections in adults who have...

News Image4 months ago - Matinas BioPharma Holdings, Inc.Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides

In an acute colitis model, data show statistically significant knockdown of elevated levels of serum TNFα, reductions in tissue TNFα mRNA and improvement...

News Image4 months ago - Matinas BioPharma Holdings, Inc.Matinas BioPharma Provides Update to MAT2203 Regulatory and Development Pathway Following Feedback from FDA

Written Preliminary Comments on the Phase 3 Registration Trial for MAT2203 Move Company Closer to Full Alignment with FDA Matinas to Meet with FDA Early...

News Image7 months ago - Seeking AlphaMatinas BioPharma stock soars 80% on antifungal drug update (MTNB)

Matinas (MTNB) shares soared 80% following news that a patient with recurrent hemorrhagic cystitis was successfully treated with its antifungal drug MAT2203. Read more here.

News Image7 months ago - Matinas BioPharma Holdings, Inc.Patient with Candida krusei Infection in Matinas BioPharma’s Oral MAT2203 Expanded Access Program Achieves Complete Clinical Resolution

BEDMINSTER, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on...

News Image7 months ago - Matinas BioPharma Holdings, Inc.Matinas BioPharma to Present at Two Investment Conferences in October 2023

BEDMINSTER, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on...

MTNB Links
Follow us for more